Cholesterol control for subclinical coronary atherosclerosis in subjects without indication for statin therapy
Park HW, Kim YG, Park GM, et al.
Am J Cardiol. 2021;S0002-9149(21)00493-8.
Leggi
Diabetes technology use for management of type 1 diabetes is associated with fewer adverse covid-19 outcomes: findings from the T1D Exchange COVID-19 Surveillance Registry
Noor N, Ebekozien O, Levin L, et al.
Diabetes Care. 2021;dc210074.
Leggi
Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC Study
Jacobson AM, Ryan CM, Braffett BH, et al.
Lancet Diabetes Endocrinol. 2021;9(7):436-445.
Leggi
The origin of the special issue on “100 Years of Experience with Insulin”
Ceriello A
Diabetes Res Clin Pract. 2021;108864.
Leggi
DMT2-CODE – Diabete Mellito Tipo 2 e Covid-19: la Pandemia nella Pandemia
Carissimi Soci, siamo lieti di portare alla Vostra conoscenza un progetto realizzato da Aristea Education "DMT2-CODE - Diabete Mellito Tipo 2 e Covid-19: la Pandemia nella Pandemia" - Board Scientifico: Prof. Agostino Consoli, Presidente SID, Dott. Paolo Di Bartolo, Presidente AMD. L'evento si articola in una serie di webinar che coinvolgeranno…
Leggi
Le prospettive future della cura del diabete di tipo 1
LE PROSPETTIVE FUTURE DELLA CURA DEL DIABETE MELLITO DI TIPO 1 I soci AMD possono scaricare il documento tramite inserimento delle proprie credenziali di accesso all’area riservata. Il documento è altresì consultabile QUI.
Leggi
Triglyceride–rich lipoproteins, apolipoproteins, and atherosclerotic cardiovascular events among patients with diabetes mellitus and end–stage renal disease on hemodialysis
Lamprea–Montealegre JA, Katz R, Scharnagl H, et al.
The American Journal of Cardiology. Pub. online 6 June 2021
Leggi
Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes
Karter AJ, Parker MM, Moffet HH, et al.
JAMA. 2021;325(22):2273-2284.
Leggi
Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study
Pylypchuk R, Wells S, Kerr A, et al.
The Lancet. Pub. online 2 June 2021
Leggi
Liver-targeting drugs and their effect on blood glucose and hepatic lipids.
Gastaldelli, A., Stefan, N. & Häring, HU
Diabetologia. 2021;64:1461-1479
Leggi